Josef Penninger, MD

Josef Penninger is the founding scientific director of IMBA and oversees all research activities at the institute. He studied Medicine and Arts at the University Innsbruck and worked as post-doctoral fellow since 1990 at the Ontario Cancer Institute. He is a Professor of Genetics at the University of Vienna, an Adjunct Full Professor of Immunology and Medical Biophysics at the University of Toronto, and holds a Honorary Professorship from the Chinese Academy of Medical Sciences. Josef worked for 13 years with Amgen Inc., the Ontario Cancer Institute, and the University of Toronto in Canada and is the founder of APEIRON Biologics.
> more

 

Lukas Kadawy

He served as Chief Financial Officer (CFO) for Apeiron from 2005 until 2015 and is presently acting as interim CFO in an advisory role.
> more

 

Ulrich Granzer, PhD

Ulrich Granzer has a wide range of experience in all aspects of drug development and regulatory affairs, including drug safety and GXP.
> more

 

Friedrich Lottspeich, MD PhD

Head of Protein Analysis, Max Planck Institute for Biochemistry, Martinsried. He is one of the leading international experts in the area of proteomics, more than 650 scientific publications.
> more

 

Gavin Oudit, MD

Clinician-Scientist, Assistant Professor at the Mazankowski Alberta Heart Institute, Edmonton
> more

 

Hellmut Samonigg, MD

Specialist in internal medicine and hemato-oncology, Head of the Department of Oncology, University Clinic of Internal Medicine, Graz
> more

 

Arthur Slutsky, MD

St. Michael’s Hospital, University Toronto. Clinical expert in acute respiratory failure, mechanical ventilation, acute lung injury, and respective translational research; more than 290 scientific publications.
> more

 

Wolfgang Stoiber, MD

Wolfgang Stoiber has over 25 years experience as a physician, pharmaceutical industry executive and as an investment banker.
> more